Artivion, Inc. (AORT) is a publicly traded Healthcare sector company. As of September 11, 2026, AORT trades at $24.65 with a market cap of $1.23B and a P/E ratio of 111.59. AORT moved -2.26% today. Year to date, AORT is -44.56%; over the trailing twelve months it is -39.94%. Its 52-week range spans $19.16 to $48.25. Analyst consensus is strong buy with an average price target of $41.87. Rallies surfaces AORT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Artivion, Inc. (AORT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AORT moved -2.26% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $24.65 |
| Market Cap | $1.23B |
| P/E Ratio | 111.59 |
| EPS | $0.22 |
| Dividend Yield | 0.03% |
| 52-Week High | $48.25 |
| 52-Week Low | $19.16 |
| Volume | 426.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $441.33M |
| Net Income | $9.77M |
| Gross Margin | 64.40% |
6 analysts cover AORT: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.87.